It may seem a distant spec on the horizon, but at some point all innovators will want to submit their potential healthcare solution for regulatory approval. What a shame it would be – for innovators, investors ánd patients – if they would need to back-track, because they missed out on some essentials early on. Why not start at the end? Tap into Benelux expertise and familiarize yourself with what regulators may need and work back to design your procedures and strategy.
Join “Start at the end” in which Johnson & Johnson Innovation – JLABS and unlock_ brings you a program with learnings that may help you smooth your regulatory approach. Register through http://jlabs.buzz/regulators